XLOXilio Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Xilio Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XLOEsta | $46M#8 | — | 0.6x#5 | 1.1x#1 | 589.9%#2 | 39.8%#4 | -95.9%#2 | -48.5%#4 | — | — | -28.5%#1 | — |
| CLNN | $50M#1 | — | — | 250.2x#6 | -41.5%#6 | 33.6%#5 | -11541.5%#6 | — | — | — | — | — |
| SER | $50M#2 | — | — | 384.9x#7 | 132.1%#4 | -72.2%#13 | -18478.5%#7 | — | — | 5#2 | — | — |
| HOWL | $49M#3 | — | 3.0x#9 | — | — | 13.7%#7 | — | -373.3%#11 | -229.9%#4 | — | — | — |
| HYPD | $49M#4 | — | 0.5x#2 | 60.4x#5 | 1318.8%#1 | 9.0%#10 | -5743.5%#5 | -44.5%#3 | -46.8%#2 | — | — | — |
| SKYE | $47M#5 | — | — | — | — | -110.5%#14 | — | — | — | — | — | — |
| ATNM | $47M#6 | 4.3x#2 | 1.5x#8 | 520.5x#8 | — | 11.4%#9 | -40274.4%#8 | -111.8%#9 | — | — | — | — |
| CTOR | $47M#7 | — | 1.2x#6 | — | — | -17.1%#11 | — | -61.3%#6 | — | — | — | — |
| AZTR | $46M#9 | 37.7x#4 | 6.2x#13 | — | -100.0%#8 | -22.2%#12 | — | -149.4%#10 | — | — | — | — |
| BMEA | $45M#10 | — | 3.7x#10 | — | — | 55.4%#2 | — | -509.2%#13 | — | — | — | — |
| APUS | $4M#16 | — | 0.0x#1 | — | — | -331.7%#16 | — | -5.6%#1 | -11.2%#1 | — | — | — |
| ELTX | $44M#11 | — | 5.6x#12 | 19.3x#4 | -91.9%#7 | 23.8%#6 | -1639.0%#4 | -498.6%#12 | — | — | — | — |
| DWTX | $42M#12 | 0.7x#1 | 0.6x#4 | — | — | -177.4%#15 | — | -50.1%#5 | — | — | — | — |
| SCYX | $37M#13 | 13.4x#3 | 0.6x#3 | 1.8x#2 | 449.9%#3 | 59.6%#1 | -78.0%#1 | -12.9%#2 | — | 7#1 | — | — |
| VERU | $37M#14 | — | 1.3x#7 | 2.2x#3 | 3.6%#5 | 39.9%#3 | -146.6%#3 | -80.1%#7 | -399.3%#5 | — | — | 0.0%#1 |
| NNVC | $35M#15 | — | 4.0x#11 | — | — | 13.2%#8 | — | -94.7%#8 | -78.2%#3 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice